书签 分享 收藏 举报 版权申诉 / 62
上传文档赚钱

类型高血压英文课件TherapeuticsinRenal.ppt

  • 上传人(卖家):晟晟文业
  • 文档编号:5144615
  • 上传时间:2023-02-14
  • 格式:PPT
  • 页数:62
  • 大小:874.50KB
  • 【下载声明】
    1. 本站全部试题类文档,若标题没写含答案,则无答案;标题注明含答案的文档,主观题也可能无答案。请谨慎下单,一旦售出,不予退换。
    2. 本站全部PPT文档均不含视频和音频,PPT中出现的音频或视频标识(或文字)仅表示流程,实际无音频或视频文件。请谨慎下单,一旦售出,不予退换。
    3. 本页资料《高血压英文课件TherapeuticsinRenal.ppt》由用户(晟晟文业)主动上传,其收益全归该用户。163文库仅提供信息存储空间,仅对该用户上传内容的表现方式做保护处理,对上传内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!
    4. 请根据预览情况,自愿下载本文。本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
    5. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007及以上版本和PDF阅读器,压缩文件请下载最新的WinRAR软件解压。
    配套讲稿:

    如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。

    特殊限制:

    部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。

    关 键  词:
    高血压 英文 课件 TherapeuticsinRenal
    资源描述:

    1、Therapeutics in Renal DiseaseDr Michael ClarksonConsultant Renal Physician CUHChronic Kidney DiseaseCommonEasy to DiagnoseEffective Therapies AvailableCKD Care SuboptimalSerum Creatinine is a Poor Marker of GFRMDRD eGFR MDRD equation Complex log rhythmic equation Integrates key variablesAgeSexCreati

    2、nineRace Urea Albumin GFR is the accepted measure of kidney function GFR is difficult to infer from serum creatinine alone Automatic reporting identifies CKD patients with apparently“normal”serum creatinine Reduces barrier to early detectionMDRD eGFRThree simple tests identify CKD in adults Dipstick

    3、 Urinalysis Haematuria/Macroalbuminuria Urine PCR-Urine protein to creatinine ratio on a“spot”urine sample 24-hour urine collections are NOT needed eGFR-Estimated GFR from serum creatinine using the MDRD equationSpot Ratios!24 hour collections cumbersome Excretion of creatinine and protein is reason

    4、ably constant throughout the day A random urine protein:creatinine ratio has been shown to correlate with a 24-hr estimation Expressed either as mg/mg(easy)or mg/mmol(multiply x 0.0088)Spot Ratios!24yo lady with ankle oedema,proteinuria and hypercholesterolaemia Spot urine protein 924mg/L Spot urine

    5、 creatinine 3343mol/L Ratio=276mg/mmol(normal:0-45)Convert to mg/mg(276 x 0.0088)=2.4g/24hrIdentifying CKDBISHBASHBOSHStaging of Chronic Kidney DiseaseStageDescriptionGFREvaluation/Plan 0At risk 90Modify risk factors 1Kidney damage/90Diagnose/Treat cause.Slownormal GFRprogression and evaluate CV ris

    6、k.2Mild 60-89Estimate progression 3 Moderate30-59 Evaluate and treat complications 4Severe15-29 Prepare for RRT 5ESRD Glomerular Disease Tubulointerstitial Disease Hypertensive NephrosclerosisInitiation FactorsProgression FactorsProgressive loss of renal functionwill occur even inthe absence of over

    7、t activity of the primary renal disorderProgression Factors Hypertension Glomerular Hypertension Proteinuria Hyperlipidemia Genetic Factors Miscellaneous Exacerbating Effect of Risk Factor Clustering Maladaptive Response to Loss of Nephron MassInitial Renal InsultLoss of Nephron MassCompensatory Glo

    8、merular Hypertrophy/HyperfiltrationMaximisation of GFR Intraglomerular HypertensionPodocyte Injury/MesangialMatrix ExpansionSecondary FSGS Proteinuria/HypertensionRAAS BlockadeBP ControlDietary ProteinRestrictionHypertension and CKDRole of Hypertension in CKD Progression50-75%of patients with CKD ha

    9、ve BP 140/90mmHgGoals of therapy 1.Retard CKD progression2.Reduce overall cardiovascular riskRole of Hypertension in CKD Progression Strong association with poor renal outcomes esp.in diabetic nephropathy Microalbuminuria progression Morphologic injury Predicts loss of renal function in non-diabetic

    10、 glomerular disorders and in APKD.Confounding effect of proteinuria make accurate assessment of independent effect difficultHypertension and CKDTarget Blood PressureRelationship between BP Control and Rate of Decline in GFR Bakris et al AJKD,2000.Decline in GFR and HTN:Stratification for Proteinuria

    11、MDRD Study:Arch Int Med,1995Effective Control of Hypertension in CKD:Multiple Agents RequiredBakris et alAJKD,2000Effective Control of Hypertension Yields Major Benefit in CKDEarly treatment can make a difference100100No TreatmentDelayedTreatmentEarly Treatment47914Kidney FailureGFR(mL/min/1.732)283

    12、Blood Pressure Goals in CKD Stratify According to Proteinuria Proteinuria 3g Goal 3gGoal 30-299mg/day300mg/dayRoutine DipstickNegativePositiveRenal SignificanceRisk MarkerMarker of progressionCardiovascular RiskIncreasedIncreasedMaladaptive Response to Loss of Nephron MassInitial Renal InsultLoss of

    13、 Nephron MassCompensatory Glomerular Hypertrophy/HyperfiltrationMaximisation of GFR Intraglomerular HypertensionPodocyte Injury/MesangialMatrix ExpansionSecondary FSGS Proteinuria/HypertensionProteinuria and CKD Proteinuria evaluation mandatory in all patients with CKD Independent risk factor for CK

    14、D progression Best predictor of ESRDAdverse Consequences of Proteinuria vs low eGFRAll-Cause Mortality(per 1000 patient yrs rate(95%CI)Normal Mild HeavyeGFR 602.7(2.6-2.8)5.8(5.5-6.0)7.2(6.6-7.8)eGFR 45-592.9(2.7-3.0)5.2(5.5-6.0)7.2(6.5-7.8)eGFR 30-444.0(3.7-4.2)5.8(5.4-6.2)7.5(6.8-8.2)eGFR 15-306.7

    15、(6.2-7.3)9.1(8.2-10.0)10.4(9.3-11.6)Hemmelgarn et al.JAMA.2010;303(5):423-429.Proteinuria In CKDIntervention StudiesPharmacologic Approaches Dietary ApproachesReduction in proteinuria Reduction in proteinuria is key to successful renoprotective strategy.Anti-hypertensive regimens with better reducti

    16、on in proteinuria afford greater renoprotective benefits.Benefit persists even when BP within the normal range.Proteinuria and CKDPharmacologic ApproachesACE-I Decrease Proteinuria More than Conventional Anti-Hypertensive Therapy Jafar et al,Meta AnalysisAnn Int Med2001RAAS Blockade in CKD-Mechanism

    17、 of Action Reduction in intraglomerular hypertension Efferent arteriolar vasodilatation Improved glomerular permselectivity Attenuation of AII-stimulated growth factor and inflammatory cytokine secretion Prevention of extracellular matrix accumulationAfferentEfferentVasodilatorsProstaglandinsNitric

    18、OxideVasoconstrictorsEndothelinCatecholaminesAdenosineVasoconstrictorsAngiotensin-IIAfferentEfferentVasodilatorsProstaglandinsNitric OxideVasoconstrictorsAngiotensin-IIPGc HyperfiltrationMechanical Strain2 FSGSEfferentRAAS BlockadePGc Hypertension ControlBPLower GFRReduction in ProteinuriaAngiotensi

    19、n Recptor BlockadeMore Risk,More Benefit!Initiation of ACE-I or ARB“Although ACE inhibitors now have a specialised role in some forms of renal disease they also occasionally cause impairment of renal function which may progress and become severe in other circumstances”BNFInitiation of ACE-I or ARBCa

    20、se Example 42 year old lady Hypertension Recurrent UTI Atrophic left kidney Pre-eclampsia x 2 BP=155/95 MAP=115 SeCr=145umol/L.MDRD GFR=50ml/min Urine Protein to Creatinine ratio:1.4Initiation of ACE-I or ARB Initiated on Ramipril 5mg qd+low salt diet Day 7.BP=145/90 Ramipril increased to 10mg qd Da

    21、y 14 BP 140/85 Repeat Creatinine=175umol/L,K+5.4mmol/L Estimated GFR=42mls/minInitiation of ACE-I or ARB Clinical Dilemma Substantial fall in GFR following RAAS blockade Hyperkalaemia Do not suspect renovascular disease Withdraw ACE-I/ARB?Initiation of RAAS Blockade:Initial reduction in GFR predicts

    22、 better outcomeAperloo et al,Kid Int,1997Initiation of ACEi/ARB10010047914Kidney FailureGFR(mL/min/1.732)283Initiation of ACE-I or ARB Continue RAAS Blockade.Accept 25%fall in GFR.Ensure it is not progressive.Goal 130/80 Review Medications Dietary K+Restriction Diuretic Add second agent Diuretic Non

    23、-dihydroperidine CCB Beta BlockerGoal Proteinuria Independent Risk Marker Therefore Needs Independent Therapeutic Goal Irrespective of BP Control Proteinuria Dose Response to RAAS Blockade May Not Parallell That of BPGoal Proteinuria 300mg/24hours or Ratio of 0.3 RAAS Blockade BP Control Protein Res

    24、trictionCase Example 56year old Bachelor Farmer Type II DMM x 2 years Retinopathy Proteinuria Living alone High salt intake Referred for management of rising serum creatinineCase Example Medications Basal Bolus Insulin Amlodipine 10mg daily 24 hour urinary sodium 160mmol/L01/200509/200601/200702/200

    25、9Creat87120140247eGFR78564723PCRBP160/90165/95165/93170/95Case ExampleRelationship between BP Control and Rate of Decline in GFR Bakris et al AJKD,2000.Interventions:Tight salt restriction(100mmol/5g)No added salt No salt in cooking Minimise pre-prepared food Ramipril 5mg 40/3mmHg BP dropCase exampl

    26、e01/200509/200601/200702/200904/200907/200902/201006/2010Creat87120140247268270260298eGFR7856472321212219PCR2.80.60.70.1BP160/90165/95165/93170/95160/75135/70130/70122/72Case ExampleNephrology ReferralCase ExampleGiving up the salt made an awful differenceSalt is a poison!By the way,Dr Horgan tells

    27、me my eyes are way betterCase exampleSummary In proteinuric CKD ACE-inhibition+5g salt restriction Diuretic(thiazide or loop eGFR)Non-dihydropyridine CCB Others Goal 130/80mmHg at least ARB in Type II DM or if ACEi cough Summary In non-proteinuric CKD 5g salt restriction ACE-i not mandatory Diuretic(thiazide or loop eGFR)Non-dihydropyridine CCB Others Goal 130/80mmHg?Beware ARVDQUESTIONS?

    展开阅读全文
    提示  163文库所有资源均是用户自行上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作他用。
    关于本文
    本文标题:高血压英文课件TherapeuticsinRenal.ppt
    链接地址:https://www.163wenku.com/p-5144615.html

    Copyright@ 2017-2037 Www.163WenKu.Com  网站版权所有  |  资源地图   
    IPC备案号:蜀ICP备2021032737号  | 川公网安备 51099002000191号


    侵权投诉QQ:3464097650  资料上传QQ:3464097650
       


    【声明】本站为“文档C2C交易模式”,即用户上传的文档直接卖给(下载)用户,本站只是网络空间服务平台,本站所有原创文档下载所得归上传人所有,如您发现上传作品侵犯了您的版权,请立刻联系我们并提供证据,我们将在3个工作日内予以改正。

    163文库